1. Biopharma execs address the challenges of a post-pandemic workplace — Bristol Myers pays $200M upfront plus $1.36B in biobucks for Agenus' preclinical TIGIT asset — Novo Nordisk nets Ph2 win for former Corvidia kidney programSee more on our front page news
    Dismiss Notice

Create Thread

Anonymous Board for Philips Pathology


(CustomImgCaptcha By Surrey Forum)


Multiple tags may be separated by commas.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.